Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009555 · ClinicalTrials.gov registry record · Phase 4
Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat
A Phase 4 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 4
- Development phase
- 86
- Enrollment target
NCT00009555 is a Phase 4 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 86 participants.
The verdict
NCT00009555, a Phase 4 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of this study is to see if treatment with testosterone will reduce abdominal fat in HIV-positive men. Many HIV patients on antiretroviral therapy show an increase in abdominal fat. Studies have shown that treatment with testosterone may decrease abdominal fat. This study will determine if testosterone will reduce abdominal fat in HIV patients.
Interventions
- DRUG Testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Est. Completion | 2006-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00009555
The ClinicalTrials.gov registry entry for NCT00009555 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testosterone is the first listed.
NCT00009555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00009555 about?
NCT00009555 is a clinical study titled "Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat". The purpose of this study is to see if treatment with testosterone will reduce abdominal fat in HIV-positive men. Many HIV patients on antiretroviral therapy show an increase in abdominal fat. Studies have shown that treatment with testosterone may decrease abdominal fat. This study will determine ...
What is the current status of trial NCT00009555?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 86 participants. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00009555?
The interventions under investigation include: Testosterone (DRUG).
Who is sponsoring clinical trial NCT00009555?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.